Abcam plc
Discovery Drive
Cambridge Biomedical Campus
Cambridge, CB2 0AX
United Kingdom
October 19, 2020
VIA EDGAR AND E-MAIL
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-6010
Attention: Ameen Hamady
Terence O’Brien
Margaret Schwartz
Joseph McCann
Re: Abcam plc
Registration Statement on Form F-1 (File No. 333-249263)
Ladies and Gentlemen:
In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form F-1 (File No. 333-249263) (the “Registration Statement”) of Abcam plc (the “Company”). We respectfully request that the Registration Statement become effective as of 4:00 p.m., Eastern Time, on October 21, 2020, or as soon as practicable thereafter. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Latham & Watkins LLP, by calling Nathan Ajiashvili at (212) 906-2916.
Thank you for your assistance in this matter.
[signature page follows]
1
Very truly yours, | ||
Abcam plc | ||
By: | /s/ Alan Hirzel | |
Name: Alan Hirzel | ||
Title: Chief Executive Officer |
cc: | (via email) |
Alan Hirzel, Abcam plc
Michael Baldock, Abcam plc
Ian D. Schuman, Latham & Watkins LLP
Robbie McLaren, Latham & Watkins LLP
Marcel R. Fausten, Davis Polk & Wardwell LLP
Yasin Keshvargar, Davis Polk & Wardwell LLP
2